IP Library Granted Patent US 8,304,386
Granted Patent B2
US 8,304,386 · App. 12/509,188 · Granted Nov 6, 2012

Long-acting growth hormone and methods of producing same

Assignee: Prolor Biotech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,304,386
App. No.
12/509,188
Granted
Nov 6, 2012
Kind
B2
Abstract

A polypeptide and polynucleotides encoding same comprising one carboxy-terminal peptide (CTP) of chorionic gonadotrophin attached to an amino terminus of a growth hormone and two carboxy-terminal peptides (CTP) of chorionic gonadotrophin attached to a carboxy terminus of a growth hormone are disclosed. Pharmaceutical compositions comprising the polypeptide and polynucleotides of the invention and methods of using same are also disclosed.

Claims (12)

1. A method of inducing growth or weight gain in a subject, comprising administering to said subject a therapeutically effective amount of a polypeptide consisting of a growth hormone attached to a single chorionic gonadotrophin carboxy terminal peptide (CTP) or a truncated single chorionic gonadotrophin carboxy terminal peptide at the amino terminus of said growth hormone, and two chorionic gonadotrophin carboxy terminal peptides attached to the carboxy terminus of said growth hormone, thereby inducing growth or weight gain in a subject.

2. The method of claim 1 , wherein the sequence of at least one chorionic gonadotrophin carboxy terminal peptide consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 2.

3. The method of claim 1 , wherein at least one chorionic gonadotrophin carboxy terminal peptide is truncated.

4. The method of claim 1 , wherein at least one chorionic gonadotrophin carboxy terminal peptide is glycosylated.

5. The method of claim 1 , wherein said growth hormone is human growth hormone.

6. A method of inducing growth or weight gain in a subject, comprising administering to said subject a therapeutically effective amount of a polypeptide consisting of a growth hormone attached to a single chorionic gonadotrophin carboxy terminal peptide (CTP) or a truncated single chorionic gonadotrophin carboxy terminal peptide at the amino terminus of said growth hormone, and two chorionic gonadotrophin carboxy terminal peptides attached to the carboxy terminus of said growth hormone and optionally a signal peptide, thereby inducing growth or weight gain in a subject.

7. The method of claim 6 , wherein the sequence of at least one chorionic gonadotrophin carboxy terminal peptide consists of an amino acid sequence selected from the group consisting of: SEQ ID NO: 1 and SEQ ID NO: 2.

8. The method of claim 6 , wherein said signal peptide is present.

9. The method of claim 8 , wherein said signal peptide comprises an amino acid sequence of SEQ ID NO: 3.

10. The method of claim 6 , wherein at least one chorionic gonadotrophin carboxy terminal peptide is truncated.

11. The method of claim 6 , wherein at least one chorionic gonadotrophin carboxy terminal peptide is glycosylated.

12. The method of claim 6 , wherein said growth hormone is human growth hormone.

Assignments (8)
SECURITY INTEREST Recorded Jul 17, 2024
From: OPKO BIOLOGICS LTD.
To: HCR INJECTION SPV, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 068407/0549 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2023
From: PROLOR BIOTECH, LLC
To: OPKO BIOLOGICS LTD.
Reel/Frame 064679/0746 →
CHANGE OF NAME Recorded May 23, 2014
From: PROLOR BIOTECH LTD.
To: OPKO BIOLOGICS LTD.
Reel/Frame 033015/0859 →
CHANGE OF NAME Recorded Mar 24, 2014
From: MODIGENETECH LTD.
To: PROLOR BIOTECH LTD.
Reel/Frame 032503/0741 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT RECEIVING PARTY DATA: PROLOR BIOTECH INC, 8000 TOWERS CRESCENT DRIVE, SUITE 1300, VIENNA, VA 22182, USA PREVIOUSLY RECORDED ON REEL 023623 FRAME 0951. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECT RECEIVING PARTY DATA: MODIGENETECH LTD, 3 PINCHAS SAPIR, KIRYAT WEIZMANN, NES ZIONA, 74140, ISRAEL. Recorded Aug 12, 2013
From: FARES, FUAD; FIMA, UDI EYAL
To: MODIGENETECH LTD
Reel/Frame 031003/0437 →
DECLARATION TO CORRECT ASSIGNMENT Recorded Dec 18, 2012
From: FARES, FUAD; FIMA, UDI EYAL
To: PROLOR BIOTECH INC.
Reel/Frame 029486/0514 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 24, 2011
From: FARES, FUAD; FIMA, UDI EYAL
To: PROLOR BIOTECH LTD.
Reel/Frame 027104/0629 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2009
From: FARES, FUAD; FIMA, UDI EYAL
To: PROLOR BIOTECH INC.
Reel/Frame 023623/0951 →
Continuity (5)
Continuation In Part 12476916 · Jun 2, 2009
Continuation In Part 12401746 · Mar 11, 2009
Continuation 11700911 · Feb 1, 2007
Provisional Application 60764761 · Feb 3, 2006
Related Publication 20100081614A1 · Apr 1, 2010